home All News open_in_new Full Article

China closes biotech gap with US as new drugs, pipelines top 30% of global total

China’s push to become a biotech powerhouse is paying off, with innovative R&D pipelines and newly approved drugs accounting for over 30 per cent of the global total, according to the country’s top economic planner. The sector was showing strong momentum, said Xiang Libin, deputy chairman of the National Development and Reform Commission (NDRC), who cited the figures at the 17th China Bioindustry Convention in Wuhan, Hubei province, on Thursday. China’s bioeconomy, encompassing the research,...


today 20 h. ago attach_file Events

attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Events
attach_file Politics
attach_file Events
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics


ID: 357718837
Add Watch Country

arrow_drop_down